ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Silence Therapeutics PLC

Silence Therapeutics PLC (SLN)

21.74
0.00
(0.00%)
Closed July 24 4:00PM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
21.74
Bid
21.32
Ask
22.33
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
21.74
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
36,747,555
Dividend Yield
-
PE Ratio
-6.45
Earnings Per Share (EPS)
-1.18
Revenue
25.38M
Net Profit
-43.27M

About Silence Therapeutics PLC

Silence Therapeutics PLC is one of the leading companies in the ribonucleic acid (RNA) technology field. The United Kingdom-based firm focused on discovering and developing novel molecules incorporating short interfering ribonucleic acid, or siRNA, to inhibit the expression of specific target genes ... Silence Therapeutics PLC is one of the leading companies in the ribonucleic acid (RNA) technology field. The United Kingdom-based firm focused on discovering and developing novel molecules incorporating short interfering ribonucleic acid, or siRNA, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet medical needs. Its income consists of royalty income and revenue from collaboration agreements. Its geographical segments are the United Kingdom, the United States, and Germany. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
London, Gbr
Founded
1970
Silence Therapeutics PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SLN. The last closing price for Silence Therapeutics was $21.74. Over the last year, Silence Therapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

Silence Therapeutics currently has 36,747,555 shares outstanding. The market capitalization of Silence Therapeutics is $798.89 million. Silence Therapeutics has a price to earnings ratio (PE ratio) of -6.45.

SLN Latest News

Silence Therapeutics Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients

Divesiran eliminated the need for phlebotomy in all well-controlled patients following infrequent dosing and was well tolerated Data support advancing divesiran into Phase 2 Company to host...

Silence Therapeutics Achieves $2 Million Research Milestone Payment from Hansoh Pharma Collaboration

Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), an experienced and innovative biotechnology company committed to transforming peoples’ lives by silencing diseases through...

Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(a)

Study demonstrated highly significant and sustained reductions in Lp(a) to week 48 Data support advancing zerlasiran into phase 3 with 300 mg dose Silence Therapeutics plc, Nasdaq: SLN (“Silence”...

Silence Therapeutics to Present at Jefferies Global Healthcare Conference

Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through...

Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress

Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through...

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference

Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.1629
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 63.09
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.57
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.30
(0.00%)
0
AACGATA Creativity Global
$ 0.674
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1629
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 63.09
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.57
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.30
(0.00%)
0
AACGATA Creativity Global
$ 0.674
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1629
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 63.09
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.57
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.30
(0.00%)
0
AACGATA Creativity Global
$ 0.674
(0.00%)
0

Your Recent History

Delayed Upgrade Clock